Ephs and ephrins emanate complex bidirectional signals through which they can suppress oncogenic pathways, such as HRAS-Erk and PI3 kinase-Akt, and inhibit proliferation, migration and metastasis, while cancer cells on the other hand employ various mechanisms to abrogate these anti-tumorigenic signals. Here, EPHB2 is linked to cancer.